Skip to main content
SpringerLink
Log in

Collagen Vascular Diseases and Cutaneous Drug Reactions

  • Chapter
Cutaneous Drug Eruptions

  • 1667 Accesses

Abstract

Collagen vascular diseases (CVD) are a collection of autoimmune diseases in which a defect in the immune system causes the body to recognize its own structural proteins, primarily collagen, as foreign, resulting in self-directed immune responses. Tissues composed of various forms of collagen are often affected, including arteries, tendons, and other connective tissues. For this reason, CVD is sometimes called connective-tissue disease. Environmental triggers of CVD include infections, pollutants, radiation, and medications. This chapter identifies various medications that induce or exacerbate a particular CVD, as well as the manifestations, diagnosis, and treatment options thereof. The CVD subtypes discussed in this chapter are subacute cutaneous lupus erythematosus (SCLE), dermatomyositis, polyarteritis nodosa, and scleroderma. Other autoimmune diseases often classified as collagen vascular diseases not treated in this chapter include rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

General

  • Ali A. Dermatology: a pictorial review. 2nd ed. New York: McGraw-Hill; 2010.

    Google Scholar 

  • Odom RB, James WD, Berger TG. Diseases of the skin. 9th ed. St. Louis: WB Saunders Co; 2000.

    Google Scholar 

Subacute Cutaneous Lupus Erythematosus

  • Abbott RA, May K, Motley RJ. Subacute cutaneous lupus erythematosus associated with radioiodine treatment. Clin Exp Dermatol. 2012;37(7):753–4.

    Article  CAS  PubMed  Google Scholar 

  • Cabanillas M, Suarez-Amor O, Ramirez-Santos A, Gonzalez-Villas D, Nunez-Acevedo B, Monteagudo B, et al. Lamotrigine induced subacute cutaneous lupus erythematosus. Dermatol Online J. 2012;18(8):12.

    CAS  PubMed  Google Scholar 

  • Cemil BC, Atas H, Canpolat F, Akca Y, Sasmaz R. Infliximab-induced discoid lupus erythematosus. Lupus. 2013;22(5):515–8.

    Article  CAS  PubMed  Google Scholar 

  • Cleaver N, Ramirez J, Gildenberg S. Cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature. J Drugs Dermatol. 2013;12(9):1052–5.

    PubMed  Google Scholar 

  • Dalle Vedove C, Simon JC, Girolomoni G. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFa agents. J Dtsch Dermatol Ges (English, German). 2012;10(12):889–97.

    Google Scholar 

  • DeFelice T, Lu P, Lloyd A, Patel R, Franks Jr AG. Livedo racemosa, secondary to drug-induced systemic lupus erythematosus. Dermatol Online J. 2010;16(11):24.

    PubMed  Google Scholar 

  • Grönhagen CM, Fored CM, Linder M, Granath F, Nyberg F. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case–control study of 234 patients in Sweden. Br J Dermatol. 2012;167(2):296–305.

    Article  PubMed  Google Scholar 

  • Kalinska-Bienias A, Kowalewski C, Wozniak K. Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids. Postepy Dermatol Alergol. 2013;30(4):261–4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Kindem S, Llombart B, Requena C, Ruiz A, Traves V, Guillen C, et al. Subacute cutaneous lupus erythematosus after treatment with capecitabine. J Dermatol. 2013;40(1):75–6.

    Article  PubMed  Google Scholar 

  • Lamond NW, Younis T, Purdy K, Dorreen MS. Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy. Curr Oncol. 2013;20(5):e484–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lin J, Vleugels R, Callen J. Wells M, Libow L. Systemic lupus erythematosus. In: Medscape. 2014. http://emedicine.medscape.com/article/1065657-overview. Accessed 29 June 2014.

  • Lowe G, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011;14(3):465–72.

    Google Scholar 

  • Marchetti MA, Noland MM, Dillon PM, Greer KE. Taxane associated subacute cutaneous lupus erythematosus. Dermatol Online J. 2013;19(8):19259.

    CAS  PubMed  Google Scholar 

  • Marzano AV, Tavecchio S, Menicanti C, Crosti C. Drug-induced lupus erythematosus. G Ital Dermatol Venereol. 2014;149(3):301–9.

    CAS  PubMed  Google Scholar 

  • Miller KK, Chu J, Patel R, Kamino H. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline. Dermatol Online J. 2011;17(10):3.

    PubMed  Google Scholar 

  • Sandholt LH, Laurinaviciene R, Bygum A. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2014;170(2):342–51.

    Article  Google Scholar 

  • Seo J, Byun H, Cho KH, Lee EB. Methimazole-induced bullous systemic lupus erythematosus: a case report. J Korean Med Sci. 2012;27(7):818–21.

    Article  PubMed Central  PubMed  Google Scholar 

Dermatomyositis

  • Dicaro D, Bowen C, Dalton SR. Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis. J Am Acad Dermatol. 2014;70(3):e64–5.

    Article  PubMed  Google Scholar 

  • Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther. 2007;20(4):160–74.

    Article  PubMed  Google Scholar 

  • Liu SW, Velez NF, Lam C, Femia A, Granter SR, Townsend HB, et al. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis. JAMA Dermatol. 2013;149(10):1204–8.

    Article  PubMed  Google Scholar 

  • Pelle M, Callen J. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol. 2002;138(9):1231–3.

    Article  PubMed  Google Scholar 

  • Riolo G, Towheed TE. Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis. J Rheumatol. 2012;39(1):192–4.

    PubMed  Google Scholar 

  • Seidler AM, Gottlieb AB. Dermatomyositis induced by drug therapy: a review of case reports. J Am Acad Dermatol. 2008;59(5):872–80.

    Article  PubMed  Google Scholar 

  • Tong PL, Yu LL, Chan JJ. Drug-induced dermatomyositis after zoledronic acid. Australas J Dermatol. 2012;53(4):e73–5.

    Article  PubMed  Google Scholar 

  • Vasconcelos OM, Campbell WW. Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake. Muscle Nerve. 2004;30(6):803–7.

    Article  PubMed  Google Scholar 

  • Wojnarowska F. Dermatomyositis induced by penicillamine. J R Soc Med. 1980;73(12):884–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Zappala TM, Rodins K, Muir J. Hydroxyurea induced dermatomyositis-like eruption. Australas J Dermatol. 2012;53(3):e58–60.

    Article  PubMed  Google Scholar 

Polyarteritis Nodosa

  • Contreras-Steyls M, Lopez-Navarro N, Gallego E, Moyano B, Estrada D, Herrera E. Gemcitabine therapy-associated cutaneous vasculitis with a polyarteritis nodosa-like pattern. Int J Dermatol. 2013;52(8):1019–31.

    Article  Google Scholar 

  • Culver B, Itkin A, Pischel K. Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum. 2005;53(3):468–70.

    Article  PubMed  Google Scholar 

Scleroderma

  • Haustein UF, Haupt B. Drug-induced scleroderma and sclerodermiform conditions. Clin Dermatol. 1998;16(3):353–66.

    Article  CAS  PubMed  Google Scholar 

  • Konishi Y, Sato H, Sato N, Fujimoto T, Fukuda J, Tanaka T. Scleroderma-like cutaneous lesions induced by paclitaxel and carboplatin for ovarian carcinoma, not a single course of carboplatin, but re-induced and worsened by previously administered paclitaxel. J Obstet Gynaecol Res. 2010;36(3):693–6.

    Article  PubMed  Google Scholar 

  • Martinez F, Gavin J, Perez A, Gonzalez J. Scleroderm-like syndrome due to hydroxyurea. Clin Exp Dermatol. 2012;37(7):755–8.

    Article  Google Scholar 

  • Nagai Y, Yamanaka Y, Nishimura S, Nakano A, Hasegawa A, Ishikawa O. Drug eruption due to bosentan in a patient with systemic sclerosis. Mod Rheumatol. 2006;16(3):188–90.

    Article  PubMed  Google Scholar 

  • Yamamoto T. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Arch Dermatol Res. 2006;297(8):333–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA

    Ritika Trikha BS

  2. University of Colorado School of Medicine, Aurora, CO, USA

    Helena R. Winston MSc, MPhil, BA

  3. Georgetown University School of Medicine, 3511 S St. SW, Washington, DC, 20007, USA

    Lindsay N. Boyers BA

  4. Columbia University College of Physicians and Surgeons, New York, NY, USA

    Chante Karimkhani BA

Authors
  1. Ritika Trikha BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helena R. Winston MSc, MPhil, BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lindsay N. Boyers BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chante Karimkhani BA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lindsay N. Boyers BA .

Editor information

Editors and Affiliations

  1. Kansas City, Kansas, USA

    John C. Hall

  2. Miraca Life Sciences, Irving, Texas, USA

    Brian J. Hall

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Trikha, R., Winston, H.R., Boyers, L.N., Karimkhani, C. (2015). Collagen Vascular Diseases and Cutaneous Drug Reactions. In: Hall, J., Hall, B. (eds) Cutaneous Drug Eruptions. Springer, London. https://doi.org/10.1007/978-1-4471-6729-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6729-7_16

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6728-0

  • Online ISBN: 978-1-4471-6729-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation